On Dec. 16, 2019, the American College of Radiology® (ACR®) filed comments with Reps. Diana DeGette (D-CO), and Fred Upton (R-MI), of the House Energy and Commerce Committee in response to their “call to action” requesting public feedback on issues for a possible future Cures 2.0 legislative initiative.
The term “Cures 2.0” is meant to recall 2016’s landmark bipartisan 21st Century Cures Act, which authorized national research initiatives, clarified FDA jurisdiction over medical software and mandated the ACR-endorsed information blocking prohibitions, among many other directives. A future Cures 2.0 bill could potentially provide clarifications related to federal oversight of digital health products, changes to Medicare/Medicaid payments for services provided by digital health products and enhancements to health information exchange-related federal initiatives.
The ACR recommended that Congress leverage Cures 2.0 to ensure the comprehensiveness of the original information-blocking prohibitions from 2016, advance the goals of radiology’s “Ditch the Disk” initiative to modernize the exchange of medical images, and maintain FDA oversight of imaging-related digital heath products to ensure their safety and effectiveness.
Interested ACR members with questions or comments about “Cures 2.0” should contact Michael Peters, ACR director of legislative and regulatory affairs, at (202) 223-1670 or firstname.lastname@example.org.